References
1. Hardy JF, deMoerloose P, Samama CM. The coagulopathy of massive transfusion. Vox Sang 2005;89:123-127.
2. Hardcastle TC. Complications of massive transfusion in trauma patients. ISBT Science Series 2006:1:180-184.
3. Westhoff CM. Guidelines for Massive Transfusion, Bethesda, MD: AABB Press, 2005.
4. Burtelow M, Riley E, Druzin M, Fontaine M, Viele M, Goodnough L. How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion 2007;47:1564-1572
5. Stainsby D, MacLennan S, Thomas D, et al. Guidelines on the management of massive blood loss. British Journal of Haematology 2006;135:634-641.
6. Johansson PI, Hansen MB, Sorensen H. Transfusion practice in massively bleeding patients: time for a change? Vox Sang 2005;89:92-96.
7. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusion at a combat support hospital. J Trauma 2007;63(4):805-813.
8. Brecher M. Technical Manual, 15th ed. Bethesda, MD: AABB Press, 2005.
9. Clark AD, Gordon WC, Walker ID, Tait RC. 'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective. Vox Sang 2004;86:120-124.
10. Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005;59(1);8-15; discussion 15-18.
11. Eder AF, Herron R, Strupp A, et al. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Recd Cross. Transfusion 2007;47:599-607.
12. Silva MA. Standards for Blood Banks and Transfusion Services, 24th ed. Bethesda, MD: AABB Press 2006.
13. FDA Guidance for Industry, September 22, 2003, "Notifying FDA Fatalities Related to Blood Collection or Transfusion."
|